Preoperative Infection Prevention & Wound Cleansing Devices Market Research Report and Outlook by 2028

The market for preoperative infection prevention and wound cleansing devices is projected to expand from US$ 1,994.75 million in 2021 to US$ 3,112.36 million by 2028, reflecting a compound annual growth rate (CAGR) of 6.6% from 2022 to 2028.

This growth is primarily driven by the rising rates of hospital-acquired infections, an increase in surgical site infections (SSIs), and a heightened focus on effective wound management strategies. Nevertheless, the high costs associated with advanced medical devices and the complexities of reimbursement processes pose challenges to market expansion.

The preoperative phase plays a crucial role in mitigating the risk of SSIs. The use of prophylactic antibiotics can significantly decrease both the duration of hospital stays and overall healthcare costs. Consequently, wound cleansing devices serve as a cost-efficient solution to enhance wound healing by minimizing infection rates. Cleansing wounds is a fundamental step in preparing both acute and chronic wounds, as these products are designed to eliminate foreign materials and lower the risk of infection.

SSIs represent a major cause of morbidity and mortality, adversely affecting patients' health and economic productivity while imposing a substantial financial strain on healthcare systems. The future of SSI prevention globally hinges on continuous dialogue and collaboration among various stakeholders, fostering high levels of staff engagement, cultivating a robust safety culture within healthcare institutions and at national levels, and creating research opportunities that can lead to ongoing enhancements in medical procedures and healthcare frameworks. In India, there has been a swift adoption of advanced wound care technologies, driven by increasing awareness among healthcare professionals regarding the advantages and long-term cost benefits of anti-adhesion and tissue-sealing products. The surge in laparoscopic surgeries has also escalated the demand for high-quality endoscopic staplers. Furthermore, the growing prevalence of ulcers and innovations in wound therapy devices, such as pressure relief devices (PRDs), have positively influenced the preoperative infection prevention and wound cleansing devices market. PRDs are instrumental in treating pressure sores and decubitus ulcers, providing rapid relief in areas of localized skin damage. In July 2020, the University of South Australia embarked on developing a novel coating that incorporates a unique antioxidant, which can simultaneously alleviate inflammation and combat infection to enhance wound healing when applied to any dressing. In August 2019, Wound Innovations announced a contribution of US$ 5.25 million towards a research initiative in geriatric care in collaboration with Flinders University and global partner Paul Hartmann Pty Ltd. in Australia. Such research and development efforts are anticipated to lead to significant advancements in wound care devices, thereby propelling the growth of the preoperative infection prevention and wound cleansing devices market during the forecast period.

Surgical Insights

The preoperative infection prevention and wound cleansing devices market is categorized based on surgical procedures, including cataract surgery, cesarean sections, gastric bypass, appendectomy, colectomy and colostomy, esophagectomy, biopsy, cholecystectomy, mastectomy, cosmetic surgery, among others. The cosmetic surgery segment dominated the market share in 2021, while the cataract surgery segment is projected to exhibit the highest CAGR in the upcoming years. Cataracts are among the leading causes of blindness and visual impairment, developing gradually and affecting one or both eyes. Initially, cataracts may not significantly impact vision, but over time they can lead to severe visual impairment. The rise in conditions such as diabetes, obesity, and hypertension, along with an aging population, has resulted in an increase in cataract surgeries. This procedure, also known as lens replacement surgery, involves the removal of the eye's natural lens that has become cloudy due to cataracts, replacing it with an intraocular lens. Cataract surgery is the most frequently performed surgical procedure among the elderly. Effective preoperative preparation, along with intraoperative and postoperative infection control measures, is vital to prevent incisional infections in patients undergoing same-day cataract surgery. The use of perioperative antibiotics helps eliminate pathogenic organisms through bacteriostatic or bactericidal actions. Bacteriostatic agents inhibit the growth of bacteria present on the eye's surface, eyelids, or those introduced during surgery, thereby limiting infection spread while the immune system addresses non-replicating pathogens.

The Asia Pacific region is witnessing rapid growth in the preoperative infection prevention and wound cleansing devices market, with India expected to achieve the highest CAGR in this sector during the forecast period. According to the World Journal of Surgery, approximately 3,646 surgeries are conducted annually to address the surgical needs of the Indian populace. Common surgical procedures include cesarean sections, cataract surgeries, fracture repairs, and hernia operations. The prevalence of hospital-acquired infections (HAIs) in India is notably higher than in Western nations, with a consistent rise in HAI cases over the years. These infections often stem from non-compliance with infection control protocols, such as inadequate hand hygiene, reliance on outdated technologies, and the misuse of antibiotics. Such infections can lead to increased morbidity, mortality, and financial burdens on patients. Implementing effective guidelines and focusing on preventing bacterial resistance rather than solely relying on antibiotic treatments will be crucial in alleviating the disease burden. The World Health Organization (WHO) identifies Surgical Site Infection (SSI) as the most prevalent and studied type of Healthcare-Associated Infection (HAI) in low- and middle-income countries, affecting a significant proportion of surgical patients. SSI rates globally range from 0.5% to 15%, with studies in India consistently reporting higher rates between 23% and 38%. The incidence of SSI is influenced by factors such as preoperative care, the surgical environment, postoperative care, and the type of surgery performed. According to the Journal of Surgery and Surgical Research, 18,882,734 surgeries were conducted in public health facilities in India during 2019-2020, with 4,851,788 classified as major operations and 14,030,946 as minor. Among these surgeries, 23,286 patients experienced postoperative wound infections during the reference period. The increasing incidence of SSIs and HAIs, coupled with the growing number of surgical procedures in India, is driving the expansion of the preoperative infection prevention and wound cleansing devices market in the country.

The report on the preoperative infection prevention and wound cleansing devices market references primary and secondary sources, including the World Health Organization (WHO), the US Food and Drug Administration (FDA), the National Institute for Health and Care Excellence (NICE), and the National Center for Biotechnology Information (NCBI).